Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Hydroxychloroquine not able to prevent development of COVID-19, UMN trial shows

Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.

4 Jun 2020

Slow response to coronavirus led to unnecessary deaths in UK prisons, says expert

The government's slow response to recognize the impact of coronavirus on UK prisons has led to unnecessary deaths amongst its population, according to Loughborough University academic Dr Christopher Kay.

4 Jun 2020

COVID-19 can increase stroke risk in young healthy people

Young patients with no risk factors for stroke may have an increased risk if they have contracted COVID-19, whether or not they are showing symptoms of the disease.

4 Jun 2020

Research supports cautious re-opening of schools

The gradual reopening of schools, starting with primary schools, is unlikely to lead to a second wave of infection, according to new mathematical modelling of the COVID-19 outbreak from University of Warwick researchers, but we should be prepared to reintroduce lockdown measures should there be a significant rise in the number of new cases.

4 Jun 2020

Judges try to balance legal rights and courtroom health

It's tough getting people to report for jury duty in normal times. It's even harder during a pandemic.

4 Jun 2020

In hard-hit areas, COVID’s ripple effects strain mental health care systems

In late March, Marcell's girlfriend took him to the emergency room at Henry Ford Wyandotte Hospital, about 11 miles south of Detroit.

4 Jun 2020

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Eli Lilly and Company today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19.

4 Jun 2020

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19.

4 Jun 2020

Protein markers could help predict how ill a COVID-19 patient will become

Researchers at the Francis Crick Institute and Charité – Universitätsmedizin Berlin have identified 27 protein biomarkers that could be used to predict whether a patient with COVID-19 is likely to become severely ill with the disease.

4 Jun 2020

27 protein biomarkers predict COVID-19 severity in patients

Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.

4 Jun 2020

COVID‐19 epidemics could be seasonal, peaking during the cold season

Now, a new study shows the link between lower humidity and an increase in locally acquired positive cases of the coronavirus disease (COVID-19), which means that outbreaks may happen during the winter season.

4 Jun 2020

Distancing, masks and eye gear protects against spread of SARS-CoV-2 finds large study

In a comprehensive systemic analysis of different studies, researchers have found that physical distancing, use of face masks, and eye protection were the most effective ways to prevent the spread of SARS-CoV-2 infection from one person to another.

4 Jun 2020

New mobile app can help the severity of COVID-19 cases

A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases.

4 Jun 2020

Study says vitamin-magnesium combo may reduce severity of COVID-19 in seniors

The COVID-19 pandemic that began in late December 2019 has spread to over 188 countries and territories, causing over 6.5 million cases and 385,000 deaths. With no effective therapeutic COVID-19 drug or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in sight, researchers are exploring different strategies to limit its spread and mortality.

4 Jun 2020

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Hesperos Inc., pioneers of the Human-on-a-Chip in vitro system, today announced the publication of a new peer-reviewed publication that describes how the company’s technology can be used to investigate immune responses following treatment with biological therapeutics for multi-organ systemic diseases, including cancer, infectious diseases and inflammatory disorders.

4 Jun 2020

Beckman Coulter Life Sciences’ RNAdvance Viral XP kit listed for use in EUA-authorized COVID-19 testing

Beckman Coulter Life Sciences today announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease Control’s EUA-authorized COVID-19 test referenced in the FDA’s FAQ on testing for SARS-CoV-2. Laboratories are now permitted to independently validate RNAdvance Viral XP for use.

From Beckman Coulter Life Sciences 4 Jun 2020

Age and diabetes the biggest risk factors for death in pregnant COVID-19 patients

A recent research letter published on the preprint server medRxiv in June 2020 evaluates the risk factors that may lead to higher mortality in pregnant women with COVID-19 in middle-income countries.

4 Jun 2020

How COVID-19 affects people with Down Syndrome

A new study published in June 2020 on the preprint online server medRxiv reports on the increased risk of COVID-19 in Down Syndrome (DS) and certain characteristic features that are found in this population segment.

3 Jun 2020

Discharge-ready patients still breathing out SARS-CoV-2 particles, finds study

In just five months, the COVID-19 paralyzed huge cities, confined billions to their homes, and brought economic activity to a standstill in much of the world. Tens of thousands of patients became critically ill, overwhelming healthcare facilities. Even as many recovered and were ready to go home, a new study published in May 2020 on the preprint server medRxiv reports that a significant number of patients ready to go home still have virus particles in their exhaled breath.

3 Jun 2020

Chapman University survey highlights effects of COVID-19 on physical and mental health

The Chapman University National COVID-19 and Mental Health Survey provides an in-depth look at the experiences of 4,149 adults living in the United States.

3 Jun 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Hydroxychloroquine not able to prevent development of COVID-19, UMN trial shows

Slow response to coronavirus led to unnecessary deaths in UK prisons, says expert

COVID-19 can increase stroke risk in young healthy people

Research supports cautious re-opening of schools

Judges try to balance legal rights and courtroom health

In hard-hit areas, COVID’s ripple effects strain mental health care systems

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Protein markers could help predict how ill a COVID-19 patient will become

27 protein biomarkers predict COVID-19 severity in patients

COVID‐19 epidemics could be seasonal, peaking during the cold season

Distancing, masks and eye gear protects against spread of SARS-CoV-2 finds large study

New mobile app can help the severity of COVID-19 cases

Study says vitamin-magnesium combo may reduce severity of COVID-19 in seniors

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Beckman Coulter Life Sciences’ RNAdvance Viral XP kit listed for use in EUA-authorized COVID-19 testing

Age and diabetes the biggest risk factors for death in pregnant COVID-19 patients

How COVID-19 affects people with Down Syndrome

Discharge-ready patients still breathing out SARS-CoV-2 particles, finds study

Chapman University survey highlights effects of COVID-19 on physical and mental health

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in